// App-Quantinova.ai

LB-7 : Feasibility and Long Term Safety of T Regulatory Cell Therapy in Kidney Transplantation

Researchers

Presenter

  • P. N. Harden

Principal Investigators

  • D. Game

  • J. Van der Net

  • F. Issa

  • W. Petchey

  • M. Brook

  • P. Friend

  • R. Hilton

  • G. Lombardi

  • K. Wood

Medical Centers

  • Oxford Transplant Centre, Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Renal Transplantation, Guys and St Thomas Hospital, London, United Kingdom

  • Transplant Immunology Research Group, Oxford University, Oxford, United Kingdom

  • Renal Transplantation, Guys and St Thomas Hospital, London, United Kingdom

  • Transplant Immunology Group, Kings Healthcare Partners, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Plasma Renin Activity

Drug/Treatment

  • Mycophenolate mofetil

  • CKD-4101

  • Basiliximab

  • Tacrolimus

Outcome

  • N/A

Study Design

  • Dose Escalation

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved